Pharmaforte Singapore Pte Ltd

Pharmaforte Singapore Pte Ltd is a healthcare company dedicated to providing high-quality pharmaceuticals and medical devices, ensuring essential supplies for healthcare providers in Singapore and Malaysia. Pharmaforte Singapore Pte Ltd focuses on the healthcare sector, supplying pharmaceuticals and medical devices. Founded in 1995, the company is headquartered in Singapore and has engaged in a total of 1 investment deal as of January 7, 2021. The company has maintained a steady operational strategy without any noted pivots or changes in business operations.

Pharmaforte Group specializes in supplying high-quality pharmaceuticals and medical devices tailored to meet healthcare needs. The company offers a comprehensive range of products, including temperature-sensitive items such as vaccines and in-vitro diagnostic devices, catering to hospitals, clinics, and pharmacies across Malaysia and Singapore. Through partnerships with over 30 leading global principals, Pharmaforte ensures a reliable distribution of essential medical supplies to enhance patient care. In the most recent financial year, Pharmaforte Group reported a revenue of USD 39.

19 mn and an EBITDA of USD 8. 66 mn. The company generates revenue through a structured distribution model that includes both B2B and B2C transactions, selling directly to healthcare providers and through distributor partnerships, thus securing a steady flow of transactions. Pharmaforte aims to expand its product offerings and enter new markets.

The company is currently developing new medical devices and plans to launch these products in the upcoming year, focusing on enhancing their portfolio in the healthcare distribution sector. Additionally, Pharmaforte is targeting expansion into new geographic regions across Southeast Asia by the end of 2024. The recent investment from Advantage Partners in January 2021 will support these initiatives, although financial terms of the transaction were not disclosed.